Viewing Study NCT05413668


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2025-12-27 @ 10:57 AM
Study NCT ID: NCT05413668
Status: COMPLETED
Last Update Posted: 2025-04-22
First Post: 2022-05-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
Sponsor: Reveal Pharmaceuticals Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-18
Start Date Type: ACTUAL
Primary Completion Date: 2022-07-22
Primary Completion Date Type: ACTUAL
Completion Date: 2022-08-22
Completion Date Type: ACTUAL
First Submit Date: 2022-05-26
First Submit QC Date: None
Study First Post Date: 2022-06-10
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-07-22
Results First Submit QC Date: None
Results First Post Date: 2023-10-23
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-18
Last Update Post Date: 2025-04-22
Last Update Post Date Type: ACTUAL